Evidence map›Paper›PMID 32696235›Full record

ArticleDigestive diseases and sciences2021

Role of Hospital Teaching Status on Outcomes of Patients with Inflammatory Bowel Disease: A Nationwide Analysis.

Sachit Sharma, Simcha Weissman, Tej I Mehta, Muhammad Aziz, Ashu Acharya, Ishaan Vohra, Zubair Khan, Ahmad Khan, Ali Nawras, Michael Sciarra and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Digestive diseases and sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Sachit SharmaDepartment of Internal Medicine, University of Toledo Medical Center, 3000 Arlington Avenue, Toledo, OH, 43615, USA. sachitsharma@outlook.com.ORCID 0000-0003-4162-8622
Simcha WeissmanDepartment of Medicine, Hackensack University-Palisades Medical Center, North Bergen, NJ, USA.
Tej I MehtaDepartment of Medicine, University of South Dakota Sanford School of Medicine, Sioux Falls, SD, USA.
Muhammad AzizDepartment of Internal Medicine, University of Toledo Medical Center, 3000 Arlington Avenue, Toledo, OH, 43615, USA.
Ashu AcharyaDepartment of Internal Medicine, University of Toledo Medical Center, 3000 Arlington Avenue, Toledo, OH, 43615, USA.
Ishaan VohraDepartment of Internal Medicine, John H. Stroger Jr Hospital of Cook County, Chicago, IL, USA.
Zubair KhanDepartment of Gastroenterology, University of Texas Health Center at Houston, Houston, TX, USA.
Ahmad KhanDepartment of Medicine, West Virginia University Health Sciences Center Charleston Division, Charleston, WV, USA.
Ali NawrasDepartment of Gastroenterology, University of Toledo, Toledo, OH, USA.
Michael SciarraDepartment of Gastroenterology, Hackensack University-Palisades Medical Center, North Bergen, NJ, USA.
Arun SwaminathDivision of Gastroenterology, Inflammatory Bowel Disease Program, Lenox Hill Hospital, New York, NY, USA.

Funding

West Virginia IDEA-CTRU54GM104942 · NIGMS · WEST VIRGINIA UNIVERSITY · PI Laura F. Gibson · 2012 to 2026
$81.0M
NIGMS NIH HHS U54 GM104942
6 · The paper itself

Abstract

backgroundData regarding hospitalization outcomes in patients with inflammatory bowel disease (IBD) with respect to hospital teaching status are largely unknown.

aimsWe aimed to investigate the impact of hospital teaching status on IBD hospitalization outcomes.

methodsIn this retrospective analysis, we queried the 2016 and 2017 National Inpatient Sample (NIS) databases using the International Classification of Diseases 10th revision (ICD-10) coding system. All adult patients with a principal diagnosis of IBD were included. We stratified the IBD group into ulcerative colitis (UC), Crohn's disease (CD), and complicated IBD. Our primary outcome was mortality. Statistical analysis was performed using STATA, version 16.0.

resultsOf the 189,950 adult patients with IBD, the majority were admitted to teaching hospitals (70.9%). There was no significant difference in mortality based upon hospital teaching status (aOR 1.18, p = 0.48); however, these patients had an increased mean length of stay (adjusted coefficient: 0.82, p < 0.01), charges (adjusted coefficient: $8732, p < 0.01), and costs ($2871, p < 0.01). On subgroup analysis, patients with UC admitted to teaching hospitals had a significantly increased in-hospital mortality (aOR 2.11, p < 0.05), while those admitted with CD did not (aOR 0.80, p = 0.4). Among patients with complicated IBD, 73.17% were admitted to teaching hospitals, and no significant difference in in-hospital mortality was seen (aOR 1.06, p = 0.8).

conclusionWhile outcome differences are likely related to multiple unaccounted factors, greater efforts should be placed to cost-effectively manage patients with IBD at teaching institutions. Future studies are warranted to fully comprehend these variations.

Indexed as

Hospitals, TeachingAdultFemaleHumansInflammatory Bowel DiseasesMaleMiddle AgedMortalityRetrospective StudiesRisk FactorsSocioeconomic FactorsTreatment OutcomeUnited StatesCrohn’s diseaseInflammatory bowel diseasesMortalityTeaching hospitalsUlcerative colitis

Identifiers

PMID32696235
PMCPMC8385679

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.